Lenvenib 4mg Capsule contains Lenvatinib, a targeted cancer therapy used to treat advanced thyroid cancer, kidney cancer (renal cell carcinoma), and liver cancer (hepatocellular carcinoma).
| Composition | Lenvatinib |
| Manufacturer | Sun Pharmaceutical Industries Ltd |
| Packing | 7 Capsules in 1 Strip |
| Prescribed For | Thyroid Cancer, Kidney Cancer, Liver Cancer |
| Expiry | December 2027 |
Sunixar 25/50mg Capsule is an oral cancer medication containing Sunitinib Malate, used to treat advanced kidney cancer (renal cell carcinoma), gastrointestinal stromal tumors (GIST), and pancreatic neuroendocrine tumors.
| Composition | Sunitinib |
| Manufacturer | Sun Pharmaceutical Industries Ltd |
| Packing | 7 capsules in 1 Strip |
| Prescribed For | Kidney Cancer, GIST and Pancreatic Neuroendocrine Tumors |
| Expiry | December 2027 |
Sutekast 50 mg Capsule is an oral cancer medication containing Sunitinib Malate, used in the treatment of advanced cancers such as renal cell carcinoma (kidney cancer), gastrointestinal stromal tumors (GIST), and pancreatic neuroendocrine tumors.
| Composition | Sunitinib |
| Manufacturer | Aprazer Healthcare Pvt Ltd |
| Packing | 28 Capsules in 1 Bottle |
| Prescribed For | Kidney Cancer, GIST and Pancreatic Neuroendocrine Tumors |
| Expiry | December 2027 |
Enzyl 40mg capsule is an oral anti-cancer medication containing Enzalutamide, primarily used to treat advanced prostate cancer, especially castration-resistant prostate cancer (CRPC).
| Composition | Enzalutamide |
| Manufacturer | Sun Pharmaceutical Industries Ltd |
| Packing | 112 Capsules |
| Prescribed For | Prostate Cancer |
| Expiry | December 2027 |
